Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Niels Hagenaars"'
Autor:
Niels Hagenaars, Ingeborg Meijer, T M de Kruif, M. Levi, Ludo Waltman, A. Gupta, L A van de Laar
Publikováno v:
None
Background One could hypothesize that the biomedical research agenda aligns with the (global) burden of disease, since it should aim to reduce illness and death. We investigated the relationship between publication volume and Research-dependent Fract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2159a421dd097dcd0da533d35cfd94cc
https://hdl.handle.net/1887/85312
https://hdl.handle.net/1887/85312
Autor:
Lissy van de Laar, Anshu Gupta, Thijs de Kruif, Ludo Waltman, Ingeborg Meijer, Niels Hagenaars
Publikováno v:
BMJ open
BMJ open, 8(6), e020818
BMJ Open
BMJ open, 8(6), e020818
BMJ Open
Objective Since most biomedical research focuses on a specific disease, evaluation of research output requires disease-specific bibliometric indicators. Currently used methods are insufficient. The aim of this study is to develop a method that enable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26d097e77c2656f4b7addf061c7cde2
https://doi.org/10.1136/bmjopen-2017-020818
https://doi.org/10.1136/bmjopen-2017-020818
Autor:
Ethlinn V.B. van Gaal, Niels Hagenaars, Rolf J. Verheul, Wim E. Hennink, Thomas van Es, J.G.M. Heldens, Han van den Bosch, Bram Slütter, Pascal H.J.L.F. de Jong, Harrie L. Glansbeek, Enrico Mastrobattista, Ivo Que, Wim Jiskoot, Sven C. M. Bruijns
Publikováno v:
Verheul, R J, Hagenaars, N, van Es, T, van Gaal, E V B, De Jong, P H J L, Bruijns, S C M, Mastrobattista, E, Slutter, B, Que, I, Heldens, J G M, van den Bosch, J F, Glansbeek, H L, Hennink, W E & Jiskoot, W 2012, ' A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine ', European Journal of Pharmaceutical Sciences, vol. 45, no. 4, pp. 467-474 . https://doi.org/10.1016/j.ejps.2011.10.001
European Journal of Pharmaceutical Sciences, 45(4), 467-474. Elsevier
European Journal of Pharmaceutical Sciences, 45(4), 467-474
European Journal of Pharmaceutical Sciences, 45(4), 467-474. Elsevier
European Journal of Pharmaceutical Sciences, 45(4), 467-474
Recently we reported that reacetylation of N,N,N-trimethyl chitosan (TMC) reduced the adjuvant effect of TMC in mice after intranasal (i.n.) administration of whole inactivated influenza virus (WIV) vaccine. The aim of the present study was to elucid
Autor:
Pascal H.J.L.F. de Jong, Niels Hagenaars, Enrico Mastrobattista, J.G.M. Heldens, Harrie L. Glansbeek, Rolf J. Verheul, Imke Mooren, Wim E. Hennink, Han van den Bosch, Wim Jiskoot
Publikováno v:
Journal of Controlled Release. 140:126-133
The aim of this study was to assess the influence of structural properties of N,N,N-trimethyl chitosan (TMC) on its adjuvanticity. Therefore, TMCs with varying degrees of quaternization (DQ, 22-86%), O-methylation (DOM, 0-76%) and acetylation (DAc 9-
Autor:
Niels Hagenaars, Herman Vromans, Enrico Mastrobattista, Virgil E.J.C. Schijns, Harrie L. Glansbeek, Wim Jiskoot, Han van den Bosch, Didier Betbeder, J.G.M. Heldens
Publikováno v:
Vaccine. 26:6555-6563
In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split,
Autor:
Niels Hagenaars, Clemens W.G.M. Löwik, Jacco G. M. Heldens, Harrie L. Glansbeek, Han van den Bosch, Wim Jiskoot, Bram Slütter, Eric L. Kaijzel, Rob Nieuwland, Ivo Que, Enrico Mastrobattista, Pascal H.J.L.F. de Jong, Marta Mania
Publikováno v:
Journal of Controlled Release, 144(1), 17-24
Journal of Controlled Release, 144(1), 17-24. Elsevier
Hagenaars, N, Mania, M, De Jong, P, Que, I, Nieuwland, R, Slütter, B, Glansbeek, H, Heldens, J, van den Bosch, H, Löwik, C, Kaijzel, E L, Mastrobattista, E & Jiskoot, W 2010, ' Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine ', Journal of Controlled Release, vol. 144, no. 1, pp. 17-24 . https://doi.org/10.1016/j.jconrel.2010.01.027
Journal of Controlled Release, 144(1), 17-24. Elsevier
Hagenaars, N, Mania, M, De Jong, P, Que, I, Nieuwland, R, Slütter, B, Glansbeek, H, Heldens, J, van den Bosch, H, Löwik, C, Kaijzel, E L, Mastrobattista, E & Jiskoot, W 2010, ' Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine ', Journal of Controlled Release, vol. 144, no. 1, pp. 17-24 . https://doi.org/10.1016/j.jconrel.2010.01.027
The nose is a promising immunization site and intranasal (in.) vaccination studies with whole inactivated influenza virus (WIV) adjuvanted with N,N,N-trimethylchitosan (TMC-WIV) have shown promising results. In this study, the influence of TMC on the
Autor:
Enrico Mastrobattista, Niels Hagenaars, Rolf J. Verheul, Wim Jiskoot, Han van den Bosch, J.G.M. Heldens, Imke Mooren, Harrie L. Glansbeek
Publikováno v:
Pharmaceutical research. 26(6)
The purpose of this study was the development and physicochemical and immunological characterization of intranasal (i.n.) vaccine formulations of whole inactivated influenza virus (WIV) coated with N,N,N-trimethyl chitosan (TMC).Synthesized TMCs with
Nasal vaccination is a promising alternative to classical parental vaccination, as it is non-invasive and, in principle, capable of eliciting strong systemic and local immune responses. However, the protective efficacy of nasally administered antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd5b4fd2162a65bce0799534113fa8a
https://dspace.library.uu.nl/handle/1874/40363
https://dspace.library.uu.nl/handle/1874/40363
Autor:
Niels Hagenaars, Enrico Mastrobattista, Rolf Verheul, Imke Mooren, Harrie Glansbeek, Jacco Heldens, Han van den Bosch, Wim Jiskoot
Publikováno v:
Pharmaceutical Research; Jun2009, Vol. 26 Issue 6, p1353-1364, 12p